Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Receivables - Other (2017 - 2025)

Historic Receivables - Other for Summit Therapeutics (SMMT) over the last 6 years, with Q1 2025 value amounting to $12000.0.

  • Summit Therapeutics' Receivables - Other changed N/A to $12000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $12000.0, marking a year-over-year change of. This contributed to the annual value of $574000.0 for FY2021, which is N/A changed from last year.
  • As of Q1 2025, Summit Therapeutics' Receivables - Other stood at $12000.0.
  • In the past 5 years, Summit Therapeutics' Receivables - Other registered a high of $1.1 million during Q2 2022, and its lowest value of $12000.0 during Q1 2025.
  • Moreover, its 4-year median value for Receivables - Other was $322500.0 (2022), whereas its average is $397833.3.